- Home
- CMBT vs BHVN Comparison
CMBT vs BHVN Comparison
Compare CMBT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBT
- BHVN
- Stock Information
- Founded
- CMBT 1989
- BHVN 2013
- Country
- CMBT Belgium
- BHVN United States
- Employees
- CMBT N/A
- BHVN N/A
- Industry
- CMBT
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CMBT
- BHVN Health Care
- Exchange
- CMBT NYSE
- BHVN Nasdaq
- Market Cap
- CMBT 1.7B
- BHVN 1.9B
- IPO Year
- CMBT N/A
- BHVN 2017
- Fundamental
- Price
- CMBT $9.28
- BHVN $14.53
- Analyst Decision
- CMBT
- BHVN Strong Buy
- Analyst Count
- CMBT 0
- BHVN 14
- Target Price
- CMBT N/A
- BHVN $58.85
- AVG Volume (30 Days)
- CMBT 95.7K
- BHVN 1.9M
- Earning Date
- CMBT 08-07-2025
- BHVN 08-07-2025
- Dividend Yield
- CMBT 11.61%
- BHVN N/A
- EPS Growth
- CMBT N/A
- BHVN N/A
- EPS
- CMBT 2.16
- BHVN N/A
- Revenue
- CMBT $934,913,000.00
- BHVN N/A
- Revenue This Year
- CMBT $5.05
- BHVN N/A
- Revenue Next Year
- CMBT $24.22
- BHVN $59.97
- P/E Ratio
- CMBT $4.20
- BHVN N/A
- Revenue Growth
- CMBT N/A
- BHVN N/A
- 52 Week Low
- CMBT $7.65
- BHVN $13.87
- 52 Week High
- CMBT $18.43
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CMBT 48.81
- BHVN 37.53
- Support Level
- CMBT $9.15
- BHVN $14.00
- Resistance Level
- CMBT $9.75
- BHVN $14.89
- Average True Range (ATR)
- CMBT 0.22
- BHVN 0.72
- MACD
- CMBT -0.05
- BHVN 0.07
- Stochastic Oscillator
- CMBT 33.33
- BHVN 16.38
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organizes itself into three divisons: the Marine division, the H2 Infra division and the H2 Industry division. The Marine Division derives maximum revenue.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.